Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-1024x341.jpg)
![](https://www.copanusa.com/wp-content/uploads/2024/02/unnamed-640x238.png)
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-640x213.jpg)
Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
January 30, 2024
![](https://www.copanusa.com/wp-content/uploads/2024/01/Overview_4-640x213.jpg)
![](https://www.copanusa.com/wp-content/uploads/2023/07/Overview_2-640x213.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-640x213.jpg)
Colibrí™, COPAN’s Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System
October 10, 2022